17442 Federal Register / Vol. 80, No. 62 / Wednesday, April 1, 2015 / Notices 

competence of individual investigators, 

the disclosure of which would 

constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Board of Scientific 

Counselors, NIA. 

Date: May 19, 2015. 

Time: 8:00 a.m. to 8:30 a.m. 

Agenda: To review and evaluate personal 

qualifications and performance, and 

competence of individual investigators. 

Place: National Institute on Aging, 

Biomedical Research Center, 3rd Floor 

Conference Room, 251 Bayview Boulevard, 

Baltimore, MD 21224. 

Open: 8:30 a.m. to 11:45 a.m. 

Agenda: Committee discussion, individual 

presentations, laboratory overview. 

Place: National Institute on Aging, 

Biomedical Research Center, 3rd Floor 

Conference Room, 251 Bayview Boulevard, 

Baltimore, MD 21224. 

Closed: 11:45 a.m. to 12:45 p.m. 

Agenda: To review and evaluate personal 

qualifications and performance, and 

competence of individual investigators. 

Place: National Institute on Aging, 

Biomedical Research Center, 3rd Floor 

Conference Room, 251 Bayview Boulevard, 

Baltimore, MD 21224. 

Open: 12:45 p.m. to 3:00 p.m. 

Agenda: Committee discussion, individual 

presentations, laboratory overview. 

Place: National Institute on Aging, 

Biomedical Research Center, 3rd Floor 

Conference Room, 251 Bayview Boulevard, 

Baltimore, MD 21224. 

Closed: 3:00 p.m. to 4:00 p.m. 

Agenda: To review and evaluate personal 

qualifications and performance, and 

competence of individual investigators. 

Place: National Institute on Aging, 

Biomedical Research Center, 3rd Floor 

Conference Room, 251 Bayview Boulevard, 

Baltimore, MD 21224. 

Contact Person: Luigi Ferrucci, Ph.D., MD, 

Scientific Director, National Institute on 

Aging, 251 Bayview Boulevard, Suite 100, 

Room 4C225, Baltimore, MD 21224, 410– 

558–8110, LF27Z@NIH.GOV. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.866, Aging Research, 

National Institutes of Health, HHS) 

Dated: March 26, 2015. 

Melanie J. Gray, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2015–07337 Filed 3–31–15; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Neurological 

Disorders and Stroke; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of a meeting of the Board 

of Scientific Counselors, National 

Advisory Neurological Disorders and 

Stroke. 

The meeting will be closed to the 

public as indicated below in accordance 

with the provisions set forth in sections 

552b(c)(6), Title 5 U.S.C., as amended 

for the review, discussion, and 

evaluation of individual intramural 

programs and projects conducted by the 

National Institute of Neurological 

Disorders and Stroke, including 

consideration of personnel 

qualifications and performance, and the 

competence of individual investigators, 

the disclosure of which would 

constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Board of Scientific 

Counselors, National Institute of 

Neurological Disorders and Stroke. 

Date: May 17–19, 2015. 

Time: 7:00 p.m. to 10:30 a.m. 

Agenda: To review and evaluate personal 

qualifications and performance, and 

competence of individual investigators. 

Place: Residence Inn Bethesda, 7335 

Wisconsin Avenue, Bethesda, MD 20814. 

Contact Person: Alan P. Koretsky, Ph.D., 

Scientific Director, Division of Intramural 

Research, National Institute of Neurological 

Disorders and Stroke, NIH, 35 Convent Drive, 

Room 6A908, Bethesda, MD 20892, (301) 

435–2232, koretskya@ninds.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.853, Clinical Research 

Related to Neurological Disorders; 93.854, 

Biological Basis Research in the 

Neurosciences, National Institutes of Health, 

HHS). 

Dated: March 26, 2015. 

Carolyn Baum, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2015–07342 Filed 3–31–15; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Substance Abuse and Mental Health 

Services Administration 

Current List of HHS-Certified 

Laboratories and Instrumented Initial 

Testing Facilities Which Meet Minimum 

Standards To Engage in Urine Drug 

Testing for Federal Agencies 

AGENCY: Substance Abuse and Mental 

Health Services Administration, HHS. 

ACTION: Notice. 

SUMMARY: The Department of Health and 

Human Services (HHS) notifies federal 

agencies of the laboratories and 

Instrumented Initial Testing Facilities 

(IITF) currently certified to meet the 

standards of the Mandatory Guidelines 

for Federal Workplace Drug Testing 

Programs (Mandatory Guidelines). The 

Mandatory Guidelines were first 

published in the Federal Register on 

April 11, 1988 (53 FR 11970), and 

subsequently revised in the Federal 

Register on June 9, 1994 (59 FR 29908); 

September 30, 1997 (62 FR 51118); 

April 13, 2004 (69 FR 19644); November 

25, 2008 (73 FR 71858); December 10, 

2008 (73 FR 75122); and on April 30, 

2010 (75 FR 22809). 

A notice listing all currently HHScertified laboratories and IITFs is 

published in the Federal Register 

during the first week of each month. If 

any laboratory or IITF certification is 

suspended or revoked, the laboratory or 

IITF will be omitted from subsequent 

lists until such time as it is restored to 

full certification under the Mandatory 

Guidelines. 

If any laboratory or IITF has 

withdrawn from the HHS National 

Laboratory Certification Program (NLCP) 

during the past month, it will be listed 

at the end and will be omitted from the 

monthly listing thereafter. 

This notice is also available on the 

Internet at http://beta.samhsa.gov/

workplace. 

FOR FURTHER INFORMATION CONTACT: 

Giselle Hersh, Division of Workplace 

Programs, SAMHSA/CSAP, Room 7– 

1051, One Choke Cherry Road, 

Rockville, Maryland 20857; 240–276– 

2600 (voice), 240–276–2610 (fax). 

SUPPLEMENTARY INFORMATION: The 

Mandatory Guidelines were initially 

developed in accordance with Executive 

Order 12564 and section 503 of Pub. L. 

100–71. The ‘‘Mandatory Guidelines for 

Federal Workplace Drug Testing 

Programs,’’ as amended in the revisions 

listed above, requires strict standards 

that laboratories and IITFs must meet in 

order to conduct drug and specimen 

validity tests on urine specimens for 

federal agencies. 

To become certified, an applicant 

laboratory or IITF must undergo three 

rounds of performance testing plus an 

on-site inspection. To maintain that 

certification, a laboratory or IITF must 

participate in a quarterly performance 

testing program plus undergo periodic, 

on-site inspections. 

Laboratories and IITFs in the 

applicant stage of certification are not to 

be considered as meeting the minimum 

requirements described in the HHS 

Mandatory Guidelines. A HHS-certified 

laboratory or IITF must have its letter of 

certification from HHS/SAMHSA 

(formerly: HHS/NIDA), which attests 

that it has met minimum standards. 

In accordance with the Mandatory 

Guidelines dated November 25, 2008 

(73 FR 71858), the following HHSmstockstill on DSK4VPTVN1PROD with NOTICES